The antigen has been isolated from primary granulocytes (1). The antibody reacts with neutrophil granulocytes and monocytes in blood and with precursors of granulocytes in the bone marrow. The antibody is useful as an aid for classification of neoplastic tissue, i.e. myeloblasts and immature myeloid cells of acute myelogenous leukemia, progranulocytic leukemia, monomyelocytic leukemia, erythroleukemia and myeloblastoma (2).
This product is not available for purchase by the general public.
Optimized staining performance of both high and low-expression structures
Dako Omnis and the dynamic gap staining technology provides a consistent, uniform staining with excellent morphology
Crisp and clear staining with no background
Optimal laboratory efficiency with ready-to-use antibodies on Dako Omnis
The staining performance of all FLEX RTU antibodies has been defined, tested and approved through collaboration with leading, international pathology experts.
Myeloperoxidase isolated from human polymorphonuclear leucocytes.
Ready-to-use polyclonal rabbit antibody provided in liquid form in a buffer containing stabilizing protein and 0.015 mol/L NaN3.
The antibody reacts with human myeloperoxidase. In crossed immunoelectrophoresis using 12.5 µL antibody per cm2 gel area against 2 µL myeloperoxidase only one precipitate corresponding to myeloperoxidase appears. Staining: Specific staining for peroxidase. With 2 µL of human plasma, no precipitate appears. Staining: Coomassie Brilliant Blue.
In formalin-fixed, paraffin-embedded human tonsil, and when using a sensitive streptavidin-biotin-based visualization system, the antibody as expected labels only rare neutrophil granulocytes.
1. Matheson NR, Wong PS, Travis J. Isolation and properties of human neutrophil myeloperoxidase. Biochem 1981,20:325-30. 2. Pinkus GS, Pinkus JI. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol 1991,4:733-41.